Follow
Sudeep Kothari
Sudeep Kothari
Verified email at ITS.JNJ.com
Title
Cited by
Cited by
Year
Safety and immunogenicity of a Vi-DT typhoid conjugate vaccine: Phase I trial in Healthy Filipino adults and children
MR Capeding, S Teshome, T Saluja, KA Syed, DR Kim, JY Park, JS Yang, ...
Vaccine 36 (26), 3794-3801, 2018
382018
Immune suppression induced by Vi capsular polysaccharide is overcome by Vi-DT conjugate vaccine
SJ An, YK Yoon, S Kothari, DR Kim, JA Kim, N Kothari, E Lee, TH Park, ...
Vaccine 30 (6), 1023-1028, 2012
292012
Physico-chemical properties of Salmonella typhi Vi polysaccharide–diphtheria toxoid conjugate vaccines affect immunogenicity
SJ An, YK Yoon, S Kothari, N Kothari, JA Kim, E Lee, DR Kim, TH Park, ...
Vaccine 29 (44), 7618-7623, 2011
292011
A bivalent conjugate vaccine containing PspA families 1 and 2 has the potential to protect against a wide range of Streptococcus pneumoniae strains and Salmonella Typhi
N Kothari, S Kothari, YJ Choi, A Dey, DE Briles, DK Rhee, R Carbis
Vaccine 33 (6), 783-788, 2015
202015
A novel method for purification of Vi capsular polysaccharide produced by Salmonella enterica subspecies enterica serovar Typhi
S Kothari, N Kothari, JA Kim, E Lee, YK Yoon, SJ An, C Jones, WS Choe, ...
Vaccine 31 (42), 4714-4719, 2013
202013
Purification of O-specific polysaccharide from lipopolysaccharide produced by Salmonella enterica serovar Paratyphi A
S Kothari, JA Kim, N Kothari, C Jones, WS Choe, R Carbis
Vaccine 32 (21), 2457-2462, 2014
182014
Development of an efficient and scalable method for processing and purification of Vi capsular polysaccharide
S Kothari, N Kothari, E Lee, JA Kim, SJ An, YK Yoon, GW Smith, R Carbis
Procedia in Vaccinology 2 (1), 78-81, 2010
152010
Preparation and testing of a Vi conjugate vaccine using pneumococcal surface protein A (PspA) from Streptococcus pneumoniae as the carrier protein
N Kothari, KR Genschmer, S Kothari, JA Kim, DE Briles, DK Rhee, ...
Vaccine 32 (43), 5755-5760, 2014
112014
Preparation and testing of a Haemophilus influenzae Type b/Hepatitis B surface antigen conjugate vaccine
SJ An, JS Woo, MH Chae, S Kothari, R Carbis
Vaccine 33 (13), 1614-1619, 2015
92015
Spectroscopic characterisation of a series of Salmonella Typhi Vi-diphtheria toxoid glycoconjugate antigens differing in polysaccharide-protein ratio
C Jones, SJ An, YK Yoon, S Kothari, S Sahastrabuddhe, R Carbis
Journal of Pharmaceutical and Biomedical Analysis 181, 113100, 2020
72020
OL-072 Process development of an affordable bivalent conjugate vaccine against the two major causes of enteric fever, Salmonella typhi and Salmonella paratyphi A
S Kothari, JA Kim, R Carbis
International Journal of Infectious Diseases, S40, 2011
32011
Identification of collaborative cross mouse strains permissive to Salmonella enterica serovar Typhi infection
KR Alugupalli, S Kothari, MP Cravens, JA Walker, DT Dougharty, ...
Scientific Reports 13 (1), 393, 2023
12023
Collaborative Cross mice are permissive to Salmonella enterica serovar Typhi infection
K Alugupalli, S Kothari, M Cravens, J Walker, D Dougharty, G Dickinson, ...
2022
A novel method for purification of Vi capsular polysaccharide produced by Salmonella enterica subspecies enterica serovar Typhi (Vol 31, pg 4714, 2013)
S Kothari, N Kothari, JA Kim, E Lee, YK Yoon, SJ An, C Jones, WS Choe, ...
Vaccine 32 (30), 3877-3877, 2014
2014
Immune suppression induced by Vi capsular polysaccharide is overcome by Vi-DT conjugate vaccine.
ASJ An SoJung, YYK Yoon YeonKyung, S Kothari, KDR Kim DeokRyun, ...
2012
Physico-chemical properties of Salmonella typhi Vi polysaccharide-diphtheria toxoid conjugate vaccines affect immunogenicity.
ASJ An SoJung, YYK Yoon YeonKyung, S Kothari, N Kothari, ...
2011
The system can't perform the operation now. Try again later.
Articles 1–16